These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8471698)

  • 1. Seizure duration, estimation: definition vs. ECT device model.
    Gangadhar BN; Janakiramaiah N
    Biol Psychiatry; 1993 Mar; 33(5):394. PubMed ID: 8471698
    [No Abstract]   [Full Text] [Related]  

  • 2. Seizure expression during electroconvulsive therapy: relationships with clinical outcome and cognitive side effects.
    Perera TD; Luber B; Nobler MS; Prudic J; Anderson C; Sackeim HA
    Neuropsychopharmacology; 2004 Apr; 29(4):813-25. PubMed ID: 14735129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate hyperventilation prolongs electroencephalogram seizure duration of the first electroconvulsive therapy.
    Sawayama E; Takahashi M; Inoue A; Nakajima K; Kano A; Sawayama T; Okutomi T; Miyaoka H
    J ECT; 2008 Sep; 24(3):195-8. PubMed ID: 18772703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent Electroconvulsive Therapy and Bupropion Treatment.
    Takala CR; Leung JG; Murphy LL; Geske JR; Palmer BA
    J ECT; 2017 Sep; 33(3):185-189. PubMed ID: 28570500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular response and seizure duration as determined by electroencephalography during unilateral electroconvulsive therapy.
    Bergsholm P; Bleie H; Gran L; d'Elia G
    Acta Psychiatr Scand; 1993 Jul; 88(1):25-8. PubMed ID: 8372692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current status of seizure duration in the practice of electroconvulsive therapy.
    Lalla FR; Milroy T
    Can J Psychiatry; 1996 Jun; 41(5):299-304. PubMed ID: 8793149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent use of lamotrigine and electroconvulsive therapy.
    Sienaert P; Roelens Y; Demunter H; Vansteelandt K; Peuskens J; Van Heeringen C
    J ECT; 2011 Jun; 27(2):148-52. PubMed ID: 20562637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerometers for ECT seizures?
    Pridmore S
    Brain Stimul; 2013 May; 6(3):455. PubMed ID: 22546363
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of age and sex on electroconvulsive therapy using remifentanil as the sole anesthetic agent.
    Hossain A; Sullivan P
    J ECT; 2008 Sep; 24(3):232-5. PubMed ID: 18562948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconsidering the seizure threshold? A retrospective study about seizure quality among patients with maintenance ECT.
    Taib S; Levy A; Arbus C; Schmitt L; Yrondi A
    Acta Neuropsychiatr; 2019 Feb; 31(1):52-55. PubMed ID: 30398129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of etomidate on seizure duration and electrical stimulus dose in seizure-resistant patients during electroconvulsive therapy.
    Khalid N; Atkins M; Kirov G
    J ECT; 2006 Sep; 22(3):184-8. PubMed ID: 16957534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizure length in electroconvulsive therapy as a function of age, sex, and treatment number.
    Rasimas JJ; Stevens SR; Rasmussen KG
    J ECT; 2007 Mar; 23(1):14-6. PubMed ID: 17435566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electroconvulsive therapy and level of evidence: From causality to dose-effect relationship].
    Micoulaud-Franchi JA; Quilès C; Cermolacce M; Belzeaux R; Adida M; Fakra E; Azorin JM
    Encephale; 2016 Dec; 42(6S):S51-S59. PubMed ID: 28236994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does remifentanil improve ECT seizure quality?
    Gálvez V; Tor PC; Bassa A; Hadzi-Pavlovic D; MacPherson R; Marroquin-Harris M; Loo CK
    Eur Arch Psychiatry Clin Neurosci; 2016 Dec; 266(8):719-724. PubMed ID: 27038445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ictal electroencephalographic characteristics during electroconvulsive therapy: a review of determination and clinical relevance.
    Mayur P
    J ECT; 2006 Sep; 22(3):213-7. PubMed ID: 16957539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjustment of anaesthesia depth using bispectral index prolongs seizure duration in electroconvulsive therapy.
    Nishihara F; Saito S
    Anaesth Intensive Care; 2004 Oct; 32(5):661-5. PubMed ID: 15535490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility, safety, and preliminary efficacy of Low Amplitude Seizure Therapy (LAP-ST): A proof of concept clinical trial in man.
    Youssef NA; Sidhom E
    J Affect Disord; 2017 Nov; 222():1-6. PubMed ID: 28667887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exceptionally high seizure threshold: ECT device limitations.
    Lisanby SH; Devanand DP; Nobler MS; Prudic J; Mullen L; Sackeim HA
    Convuls Ther; 1996 Sep; 12(3):156-64. PubMed ID: 8872404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous theophylline is the most effective intervention to prolong EEG seizure duration in patients undergoing electroconvulsive therapy.
    Tzabazis A; Wiernik ME; Wielopolski J; Sperling W; Ihmsen H; Schmitt HJ; Münster T
    BMC Anesthesiol; 2017 Aug; 17(1):114. PubMed ID: 28851279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized Low-Amplitude Seizure Therapy: Minimizing Current for Electroconvulsive Therapy and Magnetic Seizure Therapy.
    Peterchev AV; Krystal AD; Rosa MA; Lisanby SH
    Neuropsychopharmacology; 2015 Aug; 40(9):2076-84. PubMed ID: 25920013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.